Gravitywell.Research
Company · Healthcare

SCHOTT Poonawalla.

PrivateTracked across 1 covered firm · 1 equity · 0 creditVintage Sep 2026Healthcare sector dossier
Equity holders · 1
FirmEnteredEntryStatus12-moRead
TPGMay 2025Minority buy-in, 35% from Serum Institute of India, with Novo Holdings co-investingPrivateSCHOTT Pharma retains 50% of the pharma-glass-packaging JV and SII keeps a minority slice; deal run through TPG Growth, financial terms undisclosed.

Aggregated from Gravitywell's tracked position books: covered firms only, not the full cap table. Entries, stages and reads are per-holder reconstructions from public disclosures (E). Point-in-time as of Sep 2026.

Stay ahead

New holders and status changes at SCHOTT Poonawalla, as they publish.

New reports and coverage updates. No spam. Unsubscribe anytime.